CUET UG Exam 2026 begins today, May 11, 2026. Appearing candidates can check the exam day instructions here.
Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD continuing as planned based on independent DMC review of pre-specified interim analysis - - Expect to report topline data ...
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...
Preliminary blinded data from ongoing Phase 1 trial demonstrated mean weight loss of 7% (range 0-16%) at 8 weeks in first MAD Part B cohort (n=8, ...
Mental health self-care is not a luxury reserved for recovery, but a proactive strategy essential for long-term leadership ...
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL037/AL137 (ABC-enabled antibody fo ...
Expanded mandate strengthens foundation for majority of project funding, backed by leading global lenders and export credit ...
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...
Jakafi XR and the Jakafi XR logo are trademarks of Incyte.
Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista ...
Q1 2026 Earnings Call May 5, 2026 4:30 PM EDTCompany ParticipantsRaymond Furey - Executive VP, Chief Compliance ...
The YouTube rabbit hole I recently jumped down involved watching ex-NBA players discussing Larry Bird as the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results